查詢結果分析
來源資料
相關文獻
- 第四期鼻咽癌的預後因子
- Postoperative Radiotherapy of Adult Supratentorial High-grade Astrocytoma
- A Phase Ⅱ Study of Neoadjuvant Interferon Alfa-2B and Concurrent Interferon and Radiotherapy in Primary Untreated Undifferentiated Carcinoma of Nasopharynx
- 成人低惡性度顱內星狀細胞瘤之術後放射治療
- 鼻咽癌病人放射線黏膜炎之抑制--比較Salcoat與Dexaltin之隨機取樣試驗
- 放射治療後長期存活之鼻咽癌病人的生活品質調查
- 鼻咽癌病人在放射治療前後鼓室圖之變化
- 晚期鼻咽癌同步化學放射治療與單獨放射治療臨床結果之比較--隨機分組試驗初步報告
- 不同方式放射線照射法對鼻咽癌病人唾液腺功能之影響
- Radiotherapy Versus Combined Radiotherapy and Chemotherapy for T[feb2]Nasopharyngeal Carcinoma
頁籤選單縮合
題名 | 第四期鼻咽癌的預後因子=Prognostic Factors of Stage IV Nasopharyngeal Cancer |
---|---|
作者 | 劉文山; 張慶雄; 胡渝昌; 陳建勳; 吳永平; 陳光耀; Liu, Wen-shan; Chang, Ching-hsiung; Hu, Yu-chang; Chen, Chien-hsun; Wu, Yung-ping; Chen, Kuang Y.; |
期刊 | 放射治療與腫瘤學 |
出版日期 | 19970300 |
卷期 | 4:1 1997.03[民86.03] |
頁次 | 頁1-8 |
分類號 | 416.879 |
語文 | chi |
關鍵詞 | 鼻咽癌; 放射治療; 預後因子; Nasopharyngeal cancer; Radiotherapy; Prognostic factor; |
中文摘要 | 目的:評估第四期鼻咽癌的治療成效與其預後因子。 材料與方法:從1991年4月至1995年6月間,高雄榮民總醫院共有89名可評估的T1-4N2-3MO鼻咽癌患者。所有89名患者都接受了治癒性的放射線治療;其中值劑量為7200cGy(範圍為6800至7670cGy )。本研究除計算治療後之存活率外,亦分析了T及N期別與失敗型態的關係。可能影響預後的因子均先以單變異數方法分析;有意義的預後因子再以多變異數方法分析。 結果:五年存活率、局部控制存活率與疾病控制存活率分別為43.7%、44.6%及40.3%。以單變異數方法分析,本研究發現T期別、T4腫瘤侵犯特徵、總治療時間、淋巴結放療反應、T/N期別組合、性別及血小板等均為有意義之預後因子。以多變異數方法分析,則只有T4腫瘤侵犯特徵會影響存活率,T/N期別組合會影響局部控制存活率。 結論:本研究發現第四期鼻咽癌患者的治療成果會隨不同預後因子而有所差異。以後在決定此期癌病的治療方針時,可考慮依照不同的預後因子來規劃與設計不同的治療方式,以提高治療成效。 |
英文摘要 | Purpose: To evaluate the results and prognostic factors of Stage IV naso pharyngeal cancer. Methods and Materials: From April 1991 to June 1995, 89 patients with T1-4 N2-3MO nasopharyngeal cancer treated at the Veteran General Hospital-Kaohsiung were evaluated. All these patients had received definitive radiotherapy to a median dose of 7200 cGy(range from 6800 to 7670 cGy). The failure patterns according to different T and N stages were evaluated. The possible prognostic factors were analysed by univariate analysis first, then those have significant p values were further eveluated by multivariate analysis. Reults:The survival rate, local failure free survival and disease-free survival at 5 years were 43.7%, 44.6% and 40.3%, respectively. The factors including T stage, characteristics of T4 invasion total treatment time, lymph node response rate, T and N grouping, sex and platelet counts all showed statistically significance by univariate analysis. The multivariate analysis revealed both the characteristics of T4 invasion and T/N grouping are significant to the overall survival and local failure free survival, respectively. Conclusion:This study disclosed that the patients with Stage IV nasopharyngeal cancer have different prognosis according to different factors. In the future, we might design treatment policies according to different prognostic factors in an attempt to improve the treatment results. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。